Illumina Body Map 2, young vs old
Gene Symbol | Gene ID | Gene Info |
---|---|---|
RXRG
|
ENSG00000143171.8 | retinoid X receptor gamma |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
RXRG | hg19_v2_chr1_-_165414414_165414433 | 0.51 | 2.7e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr12_+_54378923 | 3.58 |
ENST00000303460.4
|
HOXC10
|
homeobox C10 |
chr19_-_49658641 | 3.53 |
ENST00000252825.4
|
HRC
|
histidine rich calcium binding protein |
chr12_-_54982420 | 3.22 |
ENST00000257905.8
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr16_+_55357672 | 2.97 |
ENST00000290552.7
|
IRX6
|
iroquois homeobox 6 |
chr20_+_43343886 | 2.91 |
ENST00000190983.4
|
WISP2
|
WNT1 inducible signaling pathway protein 2 |
chr7_+_116166331 | 2.74 |
ENST00000393468.1
ENST00000393467.1 |
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr14_-_38725573 | 2.73 |
ENST00000342213.2
|
CLEC14A
|
C-type lectin domain family 14, member A |
chr12_+_54378849 | 2.68 |
ENST00000515593.1
|
HOXC10
|
homeobox C10 |
chr20_-_44539538 | 2.46 |
ENST00000372420.1
|
PLTP
|
phospholipid transfer protein |
chr15_+_41221536 | 2.44 |
ENST00000249749.5
|
DLL4
|
delta-like 4 (Drosophila) |
chr17_+_7184986 | 2.36 |
ENST00000317370.8
ENST00000571308.1 |
SLC2A4
|
solute carrier family 2 (facilitated glucose transporter), member 4 |
chr7_+_116139821 | 2.36 |
ENST00000393480.2
|
CAV2
|
caveolin 2 |
chr12_+_12878829 | 2.31 |
ENST00000326765.6
|
APOLD1
|
apolipoprotein L domain containing 1 |
chr7_+_116165754 | 2.30 |
ENST00000405348.1
|
CAV1
|
caveolin 1, caveolae protein, 22kDa |
chr7_+_116139744 | 2.17 |
ENST00000343213.2
|
CAV2
|
caveolin 2 |
chr14_-_61190754 | 2.15 |
ENST00000216513.4
|
SIX4
|
SIX homeobox 4 |
chr19_-_49658387 | 2.11 |
ENST00000595625.1
|
HRC
|
histidine rich calcium binding protein |
chr19_+_50706866 | 2.07 |
ENST00000440075.2
ENST00000376970.2 ENST00000425460.1 ENST00000599920.1 ENST00000601313.1 |
MYH14
|
myosin, heavy chain 14, non-muscle |
chr5_-_138730817 | 2.05 |
ENST00000434752.2
|
PROB1
|
proline-rich basic protein 1 |
chr6_+_107811162 | 2.02 |
ENST00000317357.5
|
SOBP
|
sine oculis binding protein homolog (Drosophila) |
chr3_-_38691119 | 2.01 |
ENST00000333535.4
ENST00000413689.1 ENST00000443581.1 ENST00000425664.1 ENST00000451551.2 |
SCN5A
|
sodium channel, voltage-gated, type V, alpha subunit |
chr11_-_86666427 | 2.01 |
ENST00000531380.1
|
FZD4
|
frizzled family receptor 4 |
chr1_+_202317815 | 1.99 |
ENST00000608999.1
ENST00000336894.4 ENST00000480184.1 |
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
chr10_+_88718314 | 1.99 |
ENST00000348795.4
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
chr19_-_17375527 | 1.94 |
ENST00000431146.2
ENST00000594190.1 |
USHBP1
|
Usher syndrome 1C binding protein 1 |
chr17_-_40575535 | 1.91 |
ENST00000357037.5
|
PTRF
|
polymerase I and transcript release factor |
chrX_+_38420623 | 1.90 |
ENST00000378482.2
|
TSPAN7
|
tetraspanin 7 |
chr10_+_88718397 | 1.86 |
ENST00000372017.3
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
chr19_+_35630022 | 1.84 |
ENST00000589209.1
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr17_-_38256973 | 1.81 |
ENST00000246672.3
|
NR1D1
|
nuclear receptor subfamily 1, group D, member 1 |
chr22_-_51016433 | 1.78 |
ENST00000405237.3
|
CPT1B
|
carnitine palmitoyltransferase 1B (muscle) |
chrX_+_38420783 | 1.76 |
ENST00000422612.2
ENST00000286824.6 ENST00000545599.1 |
TSPAN7
|
tetraspanin 7 |
chr5_+_131593364 | 1.76 |
ENST00000253754.3
ENST00000379018.3 |
PDLIM4
|
PDZ and LIM domain 4 |
chr8_+_144295067 | 1.75 |
ENST00000330824.2
|
GPIHBP1
|
glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1 |
chr3_-_119379427 | 1.75 |
ENST00000264231.3
ENST00000468801.1 ENST00000538678.1 |
POPDC2
|
popeye domain containing 2 |
chr17_+_39969183 | 1.74 |
ENST00000321562.4
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr3_-_119379719 | 1.72 |
ENST00000493094.1
|
POPDC2
|
popeye domain containing 2 |
chr1_-_245134273 | 1.70 |
ENST00000607453.1
|
RP11-156E8.1
|
Uncharacterized protein |
chr12_-_54982300 | 1.69 |
ENST00000547431.1
|
PPP1R1A
|
protein phosphatase 1, regulatory (inhibitor) subunit 1A |
chr19_-_4517613 | 1.67 |
ENST00000301286.3
|
PLIN4
|
perilipin 4 |
chr6_-_46459099 | 1.65 |
ENST00000371374.1
|
RCAN2
|
regulator of calcineurin 2 |
chr5_+_80529104 | 1.64 |
ENST00000254035.4
ENST00000511719.1 ENST00000437669.1 ENST00000424301.2 ENST00000505060.1 |
CKMT2
|
creatine kinase, mitochondrial 2 (sarcomeric) |
chr5_-_131562935 | 1.64 |
ENST00000379104.2
ENST00000379100.2 ENST00000428369.1 |
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
chr12_-_57634475 | 1.64 |
ENST00000393825.1
|
NDUFA4L2
|
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2 |
chr9_-_124991124 | 1.64 |
ENST00000394319.4
ENST00000340587.3 |
LHX6
|
LIM homeobox 6 |
chr17_-_73511504 | 1.60 |
ENST00000581870.1
|
CASKIN2
|
CASK interacting protein 2 |
chr16_+_222846 | 1.60 |
ENST00000251595.6
ENST00000397806.1 |
HBA2
|
hemoglobin, alpha 2 |
chr17_+_59477233 | 1.59 |
ENST00000240328.3
|
TBX2
|
T-box 2 |
chr17_+_42923686 | 1.59 |
ENST00000591513.1
|
HIGD1B
|
HIG1 hypoxia inducible domain family, member 1B |
chr19_+_35630344 | 1.59 |
ENST00000455515.2
|
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr9_-_124990680 | 1.58 |
ENST00000541397.2
ENST00000560485.1 |
LHX6
|
LIM homeobox 6 |
chr17_+_39968926 | 1.58 |
ENST00000585664.1
ENST00000585922.1 ENST00000429461.1 |
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr19_+_16999966 | 1.56 |
ENST00000599210.1
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3 |
chr19_+_35630628 | 1.55 |
ENST00000588715.1
ENST00000588607.1 |
FXYD1
|
FXYD domain containing ion transport regulator 1 |
chr11_-_46940074 | 1.52 |
ENST00000378623.1
ENST00000534404.1 |
LRP4
|
low density lipoprotein receptor-related protein 4 |
chr17_-_73511584 | 1.47 |
ENST00000321617.3
|
CASKIN2
|
CASK interacting protein 2 |
chr15_-_56035177 | 1.44 |
ENST00000389286.4
ENST00000561292.1 |
PRTG
|
protogenin |
chr19_-_47922750 | 1.43 |
ENST00000331559.5
|
MEIS3
|
Meis homeobox 3 |
chr6_+_43737939 | 1.42 |
ENST00000372067.3
|
VEGFA
|
vascular endothelial growth factor A |
chr14_+_69726968 | 1.42 |
ENST00000553669.1
|
GALNT16
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
chr7_-_107643567 | 1.40 |
ENST00000393559.1
ENST00000439976.1 ENST00000393560.1 |
LAMB1
|
laminin, beta 1 |
chr3_-_120169828 | 1.39 |
ENST00000424703.2
ENST00000469005.1 |
FSTL1
|
follistatin-like 1 |
chr3_+_28390637 | 1.39 |
ENST00000420223.1
ENST00000383768.2 |
ZCWPW2
|
zinc finger, CW type with PWWP domain 2 |
chr7_-_82073031 | 1.39 |
ENST00000356253.5
ENST00000423588.1 |
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
chr9_+_124413873 | 1.38 |
ENST00000408936.3
|
DAB2IP
|
DAB2 interacting protein |
chr15_-_71146480 | 1.37 |
ENST00000299213.8
|
LARP6
|
La ribonucleoprotein domain family, member 6 |
chr17_+_39975455 | 1.37 |
ENST00000455106.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr7_-_82073109 | 1.36 |
ENST00000356860.3
|
CACNA2D1
|
calcium channel, voltage-dependent, alpha 2/delta subunit 1 |
chr1_+_202317855 | 1.35 |
ENST00000356764.2
|
PPP1R12B
|
protein phosphatase 1, regulatory subunit 12B |
chr15_-_74043816 | 1.32 |
ENST00000379822.4
|
C15orf59
|
chromosome 15 open reading frame 59 |
chr17_+_39975544 | 1.32 |
ENST00000544340.1
|
FKBP10
|
FK506 binding protein 10, 65 kDa |
chr12_+_58003935 | 1.29 |
ENST00000333972.7
|
ARHGEF25
|
Rho guanine nucleotide exchange factor (GEF) 25 |
chr1_+_220701740 | 1.28 |
ENST00000366917.4
|
MARK1
|
MAP/microtubule affinity-regulating kinase 1 |
chr7_-_107643674 | 1.28 |
ENST00000222399.6
|
LAMB1
|
laminin, beta 1 |
chr15_-_75017711 | 1.28 |
ENST00000567032.1
ENST00000564596.1 ENST00000566503.1 ENST00000395049.4 ENST00000395048.2 ENST00000379727.3 |
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1 |
chr11_-_9113137 | 1.27 |
ENST00000520467.1
ENST00000309263.3 ENST00000457346.2 |
SCUBE2
|
signal peptide, CUB domain, EGF-like 2 |
chr11_-_47447767 | 1.27 |
ENST00000530651.1
ENST00000524447.2 ENST00000531051.2 ENST00000526993.1 ENST00000602866.1 |
PSMC3
|
proteasome (prosome, macropain) 26S subunit, ATPase, 3 |
chr16_+_28889703 | 1.26 |
ENST00000357084.3
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
chr8_-_93115445 | 1.26 |
ENST00000523629.1
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related) |
chr9_-_13279406 | 1.26 |
ENST00000546205.1
|
MPDZ
|
multiple PDZ domain protein |
chrX_+_135229559 | 1.26 |
ENST00000394155.2
|
FHL1
|
four and a half LIM domains 1 |
chr2_+_56411131 | 1.24 |
ENST00000407595.2
|
CCDC85A
|
coiled-coil domain containing 85A |
chr22_+_51176624 | 1.24 |
ENST00000216139.5
ENST00000529621.1 |
ACR
|
acrosin |
chrX_+_135229600 | 1.24 |
ENST00000370690.3
|
FHL1
|
four and a half LIM domains 1 |
chr20_+_53092123 | 1.24 |
ENST00000262593.5
|
DOK5
|
docking protein 5 |
chr16_+_28889801 | 1.23 |
ENST00000395503.4
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1 |
chr11_-_1587166 | 1.22 |
ENST00000331588.4
|
DUSP8
|
dual specificity phosphatase 8 |
chr2_+_27301435 | 1.21 |
ENST00000380320.4
|
EMILIN1
|
elastin microfibril interfacer 1 |
chr7_-_120497178 | 1.20 |
ENST00000441017.1
ENST00000424710.1 ENST00000433758.1 |
TSPAN12
|
tetraspanin 12 |
chr3_-_66024213 | 1.20 |
ENST00000483466.1
|
MAGI1
|
membrane associated guanylate kinase, WW and PDZ domain containing 1 |
chr7_-_79082867 | 1.19 |
ENST00000419488.1
ENST00000354212.4 |
MAGI2
|
membrane associated guanylate kinase, WW and PDZ domain containing 2 |
chr17_+_36584662 | 1.18 |
ENST00000431231.2
ENST00000437668.3 |
ARHGAP23
|
Rho GTPase activating protein 23 |
chrX_+_135229731 | 1.18 |
ENST00000420362.1
|
FHL1
|
four and a half LIM domains 1 |
chr17_+_58227287 | 1.17 |
ENST00000300900.4
ENST00000591725.1 |
CA4
|
carbonic anhydrase IV |
chr9_+_137533615 | 1.17 |
ENST00000371817.3
|
COL5A1
|
collagen, type V, alpha 1 |
chr11_-_2162162 | 1.16 |
ENST00000381389.1
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr4_-_154710210 | 1.15 |
ENST00000274063.4
|
SFRP2
|
secreted frizzled-related protein 2 |
chr19_-_47922373 | 1.14 |
ENST00000559524.1
ENST00000557833.1 ENST00000558555.1 ENST00000561293.1 ENST00000441740.2 |
MEIS3
|
Meis homeobox 3 |
chr6_+_30951487 | 1.13 |
ENST00000486149.2
ENST00000376296.3 |
MUC21
|
mucin 21, cell surface associated |
chr11_-_9113093 | 1.13 |
ENST00000450649.2
|
SCUBE2
|
signal peptide, CUB domain, EGF-like 2 |
chr20_+_53092232 | 1.12 |
ENST00000395939.1
|
DOK5
|
docking protein 5 |
chr19_-_17375541 | 1.12 |
ENST00000252597.3
|
USHBP1
|
Usher syndrome 1C binding protein 1 |
chr14_-_105635090 | 1.11 |
ENST00000331782.3
ENST00000347004.2 |
JAG2
|
jagged 2 |
chr11_-_57092381 | 1.11 |
ENST00000358252.3
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa |
chrX_-_132549506 | 1.09 |
ENST00000370828.3
|
GPC4
|
glypican 4 |
chr2_-_175629164 | 1.08 |
ENST00000409323.1
ENST00000261007.5 ENST00000348749.5 |
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle) |
chr3_-_50340996 | 1.08 |
ENST00000266031.4
ENST00000395143.2 ENST00000457214.2 ENST00000447605.2 ENST00000418723.1 ENST00000395144.2 |
HYAL1
|
hyaluronoglucosaminidase 1 |
chr1_-_33336414 | 1.07 |
ENST00000373471.3
ENST00000609187.1 |
FNDC5
|
fibronectin type III domain containing 5 |
chr5_-_131563501 | 1.07 |
ENST00000401867.1
ENST00000379086.1 ENST00000418055.1 ENST00000453286.1 ENST00000166534.4 |
P4HA2
|
prolyl 4-hydroxylase, alpha polypeptide II |
chr10_+_81892347 | 1.06 |
ENST00000372267.2
|
PLAC9
|
placenta-specific 9 |
chr17_-_31404 | 1.06 |
ENST00000343572.7
|
DOC2B
|
double C2-like domains, beta |
chr1_-_1850697 | 1.05 |
ENST00000378598.4
ENST00000416272.1 ENST00000310991.3 |
TMEM52
|
transmembrane protein 52 |
chr11_+_10326612 | 1.05 |
ENST00000534464.1
ENST00000530439.1 ENST00000524948.1 ENST00000528655.1 ENST00000526492.1 ENST00000525063.1 |
ADM
|
adrenomedullin |
chr16_-_75299884 | 1.04 |
ENST00000538440.2
ENST00000418647.3 |
BCAR1
|
breast cancer anti-estrogen resistance 1 |
chr2_-_175629135 | 1.04 |
ENST00000409542.1
ENST00000409219.1 |
CHRNA1
|
cholinergic receptor, nicotinic, alpha 1 (muscle) |
chr1_+_178062855 | 1.04 |
ENST00000448150.3
|
RASAL2
|
RAS protein activator like 2 |
chr11_-_47447970 | 1.03 |
ENST00000298852.3
ENST00000530912.1 |
PSMC3
|
proteasome (prosome, macropain) 26S subunit, ATPase, 3 |
chrX_+_149531524 | 1.01 |
ENST00000370401.2
|
MAMLD1
|
mastermind-like domain containing 1 |
chr16_-_70719925 | 1.00 |
ENST00000338779.6
|
MTSS1L
|
metastasis suppressor 1-like |
chr9_-_13279563 | 1.00 |
ENST00000541718.1
|
MPDZ
|
multiple PDZ domain protein |
chr2_+_46524537 | 0.98 |
ENST00000263734.3
|
EPAS1
|
endothelial PAS domain protein 1 |
chr12_-_48152428 | 0.97 |
ENST00000449771.2
ENST00000395358.3 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr5_+_170288856 | 0.96 |
ENST00000523189.1
|
RANBP17
|
RAN binding protein 17 |
chr1_+_7844312 | 0.96 |
ENST00000377541.1
|
PER3
|
period circadian clock 3 |
chr19_+_16999654 | 0.95 |
ENST00000248076.3
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3 |
chr11_+_86667117 | 0.95 |
ENST00000531827.1
|
RP11-736K20.6
|
RP11-736K20.6 |
chr3_+_125694347 | 0.95 |
ENST00000505382.1
ENST00000511082.1 |
ROPN1B
|
rhophilin associated tail protein 1B |
chr4_+_20255123 | 0.95 |
ENST00000504154.1
ENST00000273739.5 |
SLIT2
|
slit homolog 2 (Drosophila) |
chr14_+_24600484 | 0.94 |
ENST00000267426.5
|
FITM1
|
fat storage-inducing transmembrane protein 1 |
chr22_+_31489344 | 0.93 |
ENST00000404574.1
|
SMTN
|
smoothelin |
chr14_-_61191049 | 0.93 |
ENST00000556952.3
|
SIX4
|
SIX homeobox 4 |
chr19_-_46000251 | 0.92 |
ENST00000590526.1
ENST00000344680.4 ENST00000245923.4 |
RTN2
|
reticulon 2 |
chr6_+_43738444 | 0.91 |
ENST00000324450.6
ENST00000417285.2 ENST00000413642.3 ENST00000372055.4 ENST00000482630.2 ENST00000425836.2 ENST00000372064.4 ENST00000372077.4 ENST00000519767.1 |
VEGFA
|
vascular endothelial growth factor A |
chr17_+_4853442 | 0.91 |
ENST00000522301.1
|
ENO3
|
enolase 3 (beta, muscle) |
chr15_+_74218787 | 0.91 |
ENST00000261921.7
|
LOXL1
|
lysyl oxidase-like 1 |
chr9_-_123342415 | 0.90 |
ENST00000349780.4
ENST00000360190.4 ENST00000360822.3 ENST00000359309.3 |
CDK5RAP2
|
CDK5 regulatory subunit associated protein 2 |
chr9_-_112260531 | 0.90 |
ENST00000374541.2
ENST00000262539.3 |
PTPN3
|
protein tyrosine phosphatase, non-receptor type 3 |
chr1_-_154946792 | 0.90 |
ENST00000412170.1
|
SHC1
|
SHC (Src homology 2 domain containing) transforming protein 1 |
chr17_+_12569472 | 0.89 |
ENST00000343344.4
|
MYOCD
|
myocardin |
chr1_+_199996733 | 0.89 |
ENST00000236914.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
chr5_+_128301189 | 0.89 |
ENST00000395266.1
ENST00000506176.1 |
SLC27A6
|
solute carrier family 27 (fatty acid transporter), member 6 |
chr17_+_40811283 | 0.89 |
ENST00000251412.7
|
TUBG2
|
tubulin, gamma 2 |
chr5_-_132113063 | 0.88 |
ENST00000378719.2
|
SEPT8
|
septin 8 |
chr10_-_103454876 | 0.88 |
ENST00000331272.7
|
FBXW4
|
F-box and WD repeat domain containing 4 |
chr7_+_3340989 | 0.88 |
ENST00000404826.2
ENST00000389531.3 |
SDK1
|
sidekick cell adhesion molecule 1 |
chr7_+_94536514 | 0.86 |
ENST00000413325.1
|
PPP1R9A
|
protein phosphatase 1, regulatory subunit 9A |
chr17_-_1394940 | 0.86 |
ENST00000570984.2
ENST00000361007.2 |
MYO1C
|
myosin IC |
chr1_-_32210275 | 0.84 |
ENST00000440175.2
|
BAI2
|
brain-specific angiogenesis inhibitor 2 |
chr10_+_95753714 | 0.84 |
ENST00000260766.3
|
PLCE1
|
phospholipase C, epsilon 1 |
chr11_+_72281681 | 0.84 |
ENST00000450804.3
|
RP11-169D4.1
|
RP11-169D4.1 |
chr7_-_27239703 | 0.84 |
ENST00000222753.4
|
HOXA13
|
homeobox A13 |
chr7_+_94536898 | 0.84 |
ENST00000433360.1
ENST00000340694.4 ENST00000424654.1 |
PPP1R9A
|
protein phosphatase 1, regulatory subunit 9A |
chr5_-_172755056 | 0.84 |
ENST00000520648.1
|
STC2
|
stanniocalcin 2 |
chr18_-_21242833 | 0.84 |
ENST00000586087.1
ENST00000592179.1 |
ANKRD29
|
ankyrin repeat domain 29 |
chr12_+_48152774 | 0.83 |
ENST00000549243.1
|
SLC48A1
|
solute carrier family 48 (heme transporter), member 1 |
chr9_-_132515302 | 0.83 |
ENST00000340607.4
|
PTGES
|
prostaglandin E synthase |
chr11_+_8040739 | 0.83 |
ENST00000534099.1
|
TUB
|
tubby bipartite transcription factor |
chr11_-_11643540 | 0.82 |
ENST00000227756.4
|
GALNT18
|
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 18 |
chr1_+_109642799 | 0.82 |
ENST00000602755.1
|
SCARNA2
|
small Cajal body-specific RNA 2 |
chr14_-_89021077 | 0.82 |
ENST00000556564.1
|
PTPN21
|
protein tyrosine phosphatase, non-receptor type 21 |
chr16_-_11370330 | 0.81 |
ENST00000241808.4
ENST00000435245.2 |
PRM2
|
protamine 2 |
chr5_-_37839782 | 0.81 |
ENST00000326524.2
ENST00000515058.1 |
GDNF
|
glial cell derived neurotrophic factor |
chrX_+_149531606 | 0.81 |
ENST00000432680.2
|
MAMLD1
|
mastermind-like domain containing 1 |
chr19_-_474880 | 0.80 |
ENST00000382696.3
ENST00000315489.4 |
ODF3L2
|
outer dense fiber of sperm tails 3-like 2 |
chr2_+_95963052 | 0.80 |
ENST00000295225.5
|
KCNIP3
|
Kv channel interacting protein 3, calsenilin |
chr1_+_1115056 | 0.79 |
ENST00000379288.3
|
TTLL10
|
tubulin tyrosine ligase-like family, member 10 |
chr22_+_18593507 | 0.79 |
ENST00000330423.3
|
TUBA8
|
tubulin, alpha 8 |
chr5_+_128300810 | 0.79 |
ENST00000262462.4
|
SLC27A6
|
solute carrier family 27 (fatty acid transporter), member 6 |
chr22_+_18593446 | 0.78 |
ENST00000316027.6
|
TUBA8
|
tubulin, alpha 8 |
chr1_+_199996702 | 0.78 |
ENST00000367362.3
|
NR5A2
|
nuclear receptor subfamily 5, group A, member 2 |
chr18_+_56530692 | 0.78 |
ENST00000588601.1
|
ZNF532
|
zinc finger protein 532 |
chr3_+_12329358 | 0.78 |
ENST00000309576.6
|
PPARG
|
peroxisome proliferator-activated receptor gamma |
chr6_+_44194762 | 0.77 |
ENST00000371708.1
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1 |
chr12_-_102874330 | 0.77 |
ENST00000307046.8
|
IGF1
|
insulin-like growth factor 1 (somatomedin C) |
chr11_-_57089774 | 0.77 |
ENST00000527207.1
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa |
chr3_-_110612323 | 0.76 |
ENST00000383686.2
|
RP11-553A10.1
|
Uncharacterized protein |
chr19_-_48867291 | 0.76 |
ENST00000435956.3
|
TMEM143
|
transmembrane protein 143 |
chr11_+_450255 | 0.75 |
ENST00000308020.5
|
PTDSS2
|
phosphatidylserine synthase 2 |
chr17_+_3627185 | 0.75 |
ENST00000325418.4
|
GSG2
|
germ cell associated 2 (haspin) |
chr1_-_149982624 | 0.74 |
ENST00000417191.1
ENST00000369135.4 |
OTUD7B
|
OTU domain containing 7B |
chr8_-_42397037 | 0.74 |
ENST00000342228.3
|
SLC20A2
|
solute carrier family 20 (phosphate transporter), member 2 |
chr17_+_7210898 | 0.73 |
ENST00000572815.1
|
EIF5A
|
eukaryotic translation initiation factor 5A |
chr12_-_48152611 | 0.72 |
ENST00000389212.3
|
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr16_-_2007607 | 0.72 |
ENST00000565426.1
|
RPL3L
|
ribosomal protein L3-like |
chr1_-_31902614 | 0.72 |
ENST00000596131.1
|
AC114494.1
|
HCG1787699; Uncharacterized protein |
chr6_-_33267101 | 0.71 |
ENST00000497454.1
|
RGL2
|
ral guanine nucleotide dissociation stimulator-like 2 |
chr18_+_56530794 | 0.71 |
ENST00000590285.1
ENST00000586085.1 ENST00000589288.1 |
ZNF532
|
zinc finger protein 532 |
chr14_+_24867992 | 0.71 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr10_-_103603677 | 0.70 |
ENST00000358038.3
|
KCNIP2
|
Kv channel interacting protein 2 |
chr1_-_153521714 | 0.70 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
chr13_+_103046954 | 0.70 |
ENST00000606448.1
|
FGF14-AS2
|
FGF14 antisense RNA 2 |
chr7_+_116312411 | 0.70 |
ENST00000456159.1
ENST00000397752.3 ENST00000318493.6 |
MET
|
met proto-oncogene |
chr11_-_57089671 | 0.69 |
ENST00000532437.1
|
TNKS1BP1
|
tankyrase 1 binding protein 1, 182kDa |
chr2_-_242255117 | 0.69 |
ENST00000420451.1
ENST00000417540.1 ENST00000310931.4 |
HDLBP
|
high density lipoprotein binding protein |
chr22_-_30234218 | 0.69 |
ENST00000307790.3
ENST00000542393.1 ENST00000397771.2 |
ASCC2
|
activating signal cointegrator 1 complex subunit 2 |
chr12_+_52400719 | 0.69 |
ENST00000293662.4
|
GRASP
|
GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein |
chr10_-_81203972 | 0.69 |
ENST00000372333.3
|
ZCCHC24
|
zinc finger, CCHC domain containing 24 |
chr1_+_156052354 | 0.69 |
ENST00000368301.2
|
LMNA
|
lamin A/C |
chr3_-_46904946 | 0.69 |
ENST00000292327.4
|
MYL3
|
myosin, light chain 3, alkali; ventricular, skeletal, slow |
chr17_-_36906058 | 0.68 |
ENST00000580830.1
|
PCGF2
|
polycomb group ring finger 2 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.9 | 5.6 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
1.7 | 5.0 | GO:1900085 | negative regulation of peptidyl-tyrosine autophosphorylation(GO:1900085) negative regulation of inward rectifier potassium channel activity(GO:1903609) |
1.5 | 6.0 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.9 | 4.5 | GO:0075509 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.8 | 2.5 | GO:0031448 | regulation of fast-twitch skeletal muscle fiber contraction(GO:0031446) positive regulation of fast-twitch skeletal muscle fiber contraction(GO:0031448) |
0.8 | 2.3 | GO:1903570 | regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
0.8 | 3.1 | GO:1902725 | negative regulation of satellite cell differentiation(GO:1902725) |
0.7 | 2.0 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.6 | 5.0 | GO:0010732 | protein glutathionylation(GO:0010731) regulation of protein glutathionylation(GO:0010732) negative regulation of protein glutathionylation(GO:0010734) |
0.6 | 1.8 | GO:0060086 | circadian temperature homeostasis(GO:0060086) |
0.6 | 1.8 | GO:1904956 | regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.6 | 4.8 | GO:0086048 | membrane depolarization during bundle of His cell action potential(GO:0086048) |
0.5 | 2.7 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.5 | 1.6 | GO:1901207 | mammary placode formation(GO:0060596) regulation of heart looping(GO:1901207) |
0.5 | 1.5 | GO:1904395 | positive regulation of skeletal muscle acetylcholine-gated channel clustering(GO:1904395) |
0.5 | 2.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.5 | 2.3 | GO:0030822 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.4 | 2.7 | GO:0071503 | response to heparin(GO:0071503) |
0.4 | 1.3 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.4 | 1.7 | GO:1904049 | negative regulation of spontaneous neurotransmitter secretion(GO:1904049) |
0.4 | 2.0 | GO:1904073 | trophectodermal cell proliferation(GO:0001834) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.4 | 2.4 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.4 | 6.3 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
0.4 | 1.2 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.4 | 1.1 | GO:0060932 | Purkinje myocyte differentiation(GO:0003168) cardiac pacemaker cell fate commitment(GO:0060927) atrioventricular node cell fate commitment(GO:0060929) His-Purkinje system cell differentiation(GO:0060932) |
0.3 | 1.0 | GO:0061433 | cellular response to caloric restriction(GO:0061433) negative regulation of oligodendrocyte progenitor proliferation(GO:0070446) |
0.3 | 1.4 | GO:0043553 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.3 | 2.1 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.3 | 1.3 | GO:0018262 | isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine(GO:0018153) isopeptide cross-linking(GO:0018262) |
0.3 | 0.8 | GO:0072356 | chromosome passenger complex localization to kinetochore(GO:0072356) |
0.2 | 3.0 | GO:0034465 | response to carbon monoxide(GO:0034465) |
0.2 | 2.1 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.2 | 3.2 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.2 | 1.8 | GO:0032485 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.2 | 0.9 | GO:0018277 | protein deamination(GO:0018277) |
0.2 | 0.9 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.7 | GO:1903348 | positive regulation of bicellular tight junction assembly(GO:1903348) |
0.2 | 0.2 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.2 | 0.7 | GO:0034059 | response to anoxia(GO:0034059) |
0.2 | 1.1 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
0.2 | 1.7 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 0.8 | GO:2000230 | negative regulation of pancreatic stellate cell proliferation(GO:2000230) |
0.2 | 0.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.2 | 0.7 | GO:0071348 | cellular response to interleukin-11(GO:0071348) |
0.2 | 1.5 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.2 | 0.8 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.2 | 0.5 | GO:0015728 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.2 | 0.8 | GO:0015862 | uridine transport(GO:0015862) |
0.1 | 2.5 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 2.5 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 0.9 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.1 | 1.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.1 | 0.8 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.1 | 1.0 | GO:0043129 | surfactant homeostasis(GO:0043129) |
0.1 | 0.6 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.1 | 0.7 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.1 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 3.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.1 | 0.4 | GO:0046901 | tetrahydrofolylpolyglutamate biosynthetic process(GO:0046901) |
0.1 | 0.5 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.1 | 0.7 | GO:0061034 | olfactory bulb mitral cell layer development(GO:0061034) |
0.1 | 0.7 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.1 | 0.6 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.1 | 0.8 | GO:0021784 | postganglionic parasympathetic fiber development(GO:0021784) |
0.1 | 0.5 | GO:0061357 | positive regulation of Wnt protein secretion(GO:0061357) |
0.1 | 1.7 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
0.1 | 0.7 | GO:0036309 | protein localization to M-band(GO:0036309) |
0.1 | 0.2 | GO:1902612 | regulation of anti-Mullerian hormone signaling pathway(GO:1902612) negative regulation of anti-Mullerian hormone signaling pathway(GO:1902613) anti-Mullerian hormone signaling pathway(GO:1990262) |
0.1 | 1.0 | GO:0046984 | regulation of hemoglobin biosynthetic process(GO:0046984) |
0.1 | 0.7 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.1 | 1.2 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.1 | 0.9 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.1 | 0.7 | GO:1905098 | negative regulation of guanyl-nucleotide exchange factor activity(GO:1905098) |
0.1 | 0.5 | GO:0061056 | sclerotome development(GO:0061056) |
0.1 | 0.4 | GO:0032972 | regulation of muscle filament sliding speed(GO:0032972) |
0.1 | 0.3 | GO:0097535 | lymphoid lineage cell migration(GO:0097534) lymphoid lineage cell migration into thymus(GO:0097535) regulation of positive thymic T cell selection(GO:1902232) |
0.1 | 0.3 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.1 | 0.4 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 0.8 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.1 | 0.9 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.1 | 0.3 | GO:0000961 | negative regulation of mitochondrial RNA catabolic process(GO:0000961) |
0.1 | 0.7 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 0.5 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
0.1 | 0.6 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
0.1 | 0.6 | GO:0051012 | microtubule sliding(GO:0051012) |
0.1 | 0.5 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
0.1 | 1.1 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.1 | 2.1 | GO:0045899 | positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
0.1 | 0.8 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.1 | 0.5 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.1 | 0.9 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.3 | GO:0018312 | peptidyl-serine ADP-ribosylation(GO:0018312) |
0.1 | 0.5 | GO:0032910 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) negative regulation of lung blood pressure(GO:0061767) |
0.1 | 0.4 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.1 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.4 | GO:1904098 | regulation of protein O-linked glycosylation(GO:1904098) positive regulation of protein O-linked glycosylation(GO:1904100) |
0.1 | 1.1 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
0.1 | 1.5 | GO:0042118 | endothelial cell activation(GO:0042118) |
0.1 | 0.5 | GO:0010286 | heat acclimation(GO:0010286) cellular heat acclimation(GO:0070370) |
0.1 | 0.5 | GO:0099601 | regulation of neurotransmitter receptor activity(GO:0099601) |
0.1 | 0.2 | GO:0006117 | acetaldehyde metabolic process(GO:0006117) |
0.1 | 0.5 | GO:0090074 | negative regulation of protein homodimerization activity(GO:0090074) |
0.1 | 0.5 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.1 | 2.7 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.3 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.1 | 0.4 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 1.3 | GO:0008212 | mineralocorticoid biosynthetic process(GO:0006705) mineralocorticoid metabolic process(GO:0008212) |
0.1 | 0.9 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.6 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.1 | 0.3 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 1.2 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
0.1 | 1.8 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.1 | 0.7 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 0.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.1 | 2.4 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) |
0.1 | 0.8 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 2.4 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
0.1 | 0.4 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 0.4 | GO:0038195 | urokinase plasminogen activator signaling pathway(GO:0038195) |
0.1 | 0.4 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 1.0 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.1 | 0.2 | GO:0098968 | neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
0.1 | 0.5 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.0 | 0.5 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.1 | GO:2000687 | negative regulation of rubidium ion transport(GO:2000681) negative regulation of rubidium ion transmembrane transporter activity(GO:2000687) |
0.0 | 0.5 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0048213 | Golgi vesicle prefusion complex stabilization(GO:0048213) |
0.0 | 0.5 | GO:0042090 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.0 | 0.3 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.0 | 1.0 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.3 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.0 | 0.5 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.0 | 0.1 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.0 | 0.8 | GO:0035562 | protein desumoylation(GO:0016926) negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.2 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
0.0 | 1.2 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.0 | 4.0 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.0 | 0.3 | GO:0032057 | negative regulation of translational initiation in response to stress(GO:0032057) |
0.0 | 0.7 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.8 | GO:0015886 | heme transport(GO:0015886) |
0.0 | 0.7 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.3 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.0 | 1.0 | GO:0048011 | neurotrophin TRK receptor signaling pathway(GO:0048011) |
0.0 | 1.0 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.0 | 0.2 | GO:0035962 | response to interleukin-13(GO:0035962) |
0.0 | 1.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.1 | GO:1901536 | negative regulation of DNA demethylation(GO:1901536) |
0.0 | 0.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.0 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.2 | GO:0021902 | commitment of neuronal cell to specific neuron type in forebrain(GO:0021902) |
0.0 | 1.0 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 0.5 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 1.0 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 4.8 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.0 | 0.7 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.0 | 0.1 | GO:0045901 | positive regulation of translational elongation(GO:0045901) |
0.0 | 0.6 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.0 | 3.8 | GO:0002027 | regulation of heart rate(GO:0002027) |
0.0 | 0.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
0.0 | 0.1 | GO:0015910 | peroxisomal long-chain fatty acid import(GO:0015910) |
0.0 | 0.1 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.0 | 0.3 | GO:0031987 | locomotion involved in locomotory behavior(GO:0031987) |
0.0 | 0.2 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.1 | GO:1901143 | insulin catabolic process(GO:1901143) |
0.0 | 0.1 | GO:0014034 | neural crest cell fate commitment(GO:0014034) |
0.0 | 1.3 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.0 | 0.2 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.0 | 0.3 | GO:0001886 | endothelial cell morphogenesis(GO:0001886) response to hydrostatic pressure(GO:0051599) |
0.0 | 0.4 | GO:0090190 | positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
0.0 | 0.2 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.2 | GO:0033504 | floor plate development(GO:0033504) |
0.0 | 1.2 | GO:0070884 | regulation of calcineurin-NFAT signaling cascade(GO:0070884) |
0.0 | 1.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.0 | 0.1 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.0 | 1.8 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.0 | 1.2 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.6 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 1.5 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.0 | 0.3 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
0.0 | 0.3 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.0 | 0.2 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.0 | 1.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.0 | 2.0 | GO:0090102 | cochlea development(GO:0090102) |
0.0 | 0.7 | GO:0030728 | ovulation(GO:0030728) |
0.0 | 0.3 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.0 | 0.3 | GO:0050747 | positive regulation of lipoprotein metabolic process(GO:0050747) |
0.0 | 0.2 | GO:0071638 | negative regulation of monocyte chemotactic protein-1 production(GO:0071638) |
0.0 | 0.5 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.0 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.2 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.0 | 0.9 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
0.0 | 0.1 | GO:0090204 | protein localization to nuclear pore(GO:0090204) |
0.0 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.3 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.0 | 0.1 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
0.0 | 2.9 | GO:0051897 | positive regulation of protein kinase B signaling(GO:0051897) |
0.0 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
0.0 | 0.6 | GO:0043586 | tongue development(GO:0043586) |
0.0 | 3.3 | GO:0006937 | regulation of muscle contraction(GO:0006937) |
0.0 | 0.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.0 | 0.2 | GO:0060965 | negative regulation of gene silencing by miRNA(GO:0060965) |
0.0 | 0.1 | GO:0042144 | vacuole fusion, non-autophagic(GO:0042144) |
0.0 | 0.1 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.0 | 1.3 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.2 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.0 | 0.2 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.0 | 0.0 | GO:0032431 | activation of phospholipase A2 activity(GO:0032431) |
0.0 | 0.0 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.0 | 0.9 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
0.0 | 0.3 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
0.0 | 0.7 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.1 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.0 | 0.2 | GO:0002943 | tRNA dihydrouridine synthesis(GO:0002943) |
0.0 | 1.2 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.0 | 0.9 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.9 | GO:0097178 | ruffle assembly(GO:0097178) |
0.0 | 0.7 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 0.3 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.0 | 0.1 | GO:1901859 | negative regulation of mitochondrial DNA replication(GO:0090298) negative regulation of mitochondrial DNA metabolic process(GO:1901859) |
0.0 | 1.0 | GO:0071174 | mitotic spindle checkpoint(GO:0071174) |
0.0 | 1.5 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.0 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.0 | 0.2 | GO:0051382 | kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
0.0 | 0.1 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.0 | 0.4 | GO:0022011 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 2.1 | GO:0061337 | cardiac conduction(GO:0061337) |
0.0 | 0.7 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.0 | 0.1 | GO:0033173 | calcineurin-NFAT signaling cascade(GO:0033173) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.4 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.0 | 0.1 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
0.0 | 0.4 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.0 | 0.2 | GO:1903608 | protein localization to cytoplasmic stress granule(GO:1903608) |
0.0 | 0.2 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.1 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.0 | 0.1 | GO:1903490 | regulation of cytokinetic process(GO:0032954) regulation of mitotic cytokinetic process(GO:1903436) positive regulation of mitotic cytokinetic process(GO:1903438) positive regulation of mitotic cytokinesis(GO:1903490) |
0.0 | 0.6 | GO:0030261 | chromosome condensation(GO:0030261) |
0.0 | 0.3 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.0 | 0.7 | GO:0046949 | fatty-acyl-CoA biosynthetic process(GO:0046949) |
0.0 | 0.5 | GO:0060325 | face morphogenesis(GO:0060325) |
0.0 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.0 | 0.0 | GO:0071586 | CAAX-box protein processing(GO:0071586) CAAX-box protein maturation(GO:0080120) |
0.0 | 0.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.0 | 0.2 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.6 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.0 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) positive regulation of TORC1 signaling(GO:1904263) |
0.0 | 0.1 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.0 | 0.4 | GO:0006750 | glutathione biosynthetic process(GO:0006750) |
0.0 | 0.1 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.0 | 0.1 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
0.0 | 2.0 | GO:0046546 | male gonad development(GO:0008584) development of primary male sexual characteristics(GO:0046546) |
0.0 | 0.2 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.2 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.4 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.0 | 0.3 | GO:0019054 | modulation by virus of host process(GO:0019054) |
0.0 | 0.1 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.2 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.0 | 0.4 | GO:0032402 | melanosome transport(GO:0032402) |
0.0 | 0.1 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
0.0 | 0.1 | GO:0071599 | otic vesicle development(GO:0071599) |
0.0 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.0 | 0.6 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.7 | GO:0043257 | laminin-8 complex(GO:0043257) |
0.5 | 6.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.5 | 1.4 | GO:1990032 | parallel fiber(GO:1990032) |
0.4 | 1.2 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.4 | 1.2 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 1.1 | GO:0036117 | hyaluranon cable(GO:0036117) |
0.4 | 5.6 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.3 | 2.1 | GO:0097513 | myosin II filament(GO:0097513) |
0.3 | 0.3 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.3 | 5.0 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.3 | 2.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.3 | 2.0 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.2 | 1.2 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.2 | 0.9 | GO:0045160 | myosin I complex(GO:0045160) |
0.2 | 5.0 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
0.2 | 1.7 | GO:0044326 | dendritic spine neck(GO:0044326) |
0.2 | 1.5 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.2 | 2.3 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 0.9 | GO:0014802 | terminal cisterna(GO:0014802) |
0.2 | 2.7 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.1 | 0.6 | GO:0071665 | gamma-catenin-TCF7L2 complex(GO:0071665) |
0.1 | 1.0 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 3.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.1 | 4.5 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 2.9 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.1 | 1.1 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 1.5 | GO:0005642 | annulate lamellae(GO:0005642) |
0.1 | 0.9 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
0.1 | 2.4 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.1 | 1.2 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 1.6 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 2.5 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
0.1 | 1.4 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 2.1 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.1 | 0.2 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
0.1 | 0.7 | GO:0005638 | lamin filament(GO:0005638) |
0.1 | 0.7 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.1 | GO:0043614 | multi-eIF complex(GO:0043614) |
0.1 | 0.2 | GO:0035525 | NF-kappaB p50/p65 complex(GO:0035525) |
0.1 | 0.4 | GO:1990584 | cardiac Troponin complex(GO:1990584) |
0.1 | 2.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 1.9 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.1 | 0.3 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.1 | 0.6 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.8 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 5.4 | GO:0031672 | A band(GO:0031672) |
0.1 | 0.2 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.0 | 0.5 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.5 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.0 | 0.3 | GO:0005955 | calcineurin complex(GO:0005955) |
0.0 | 0.4 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 0.4 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.2 | GO:1990742 | microvesicle(GO:1990742) |
0.0 | 0.5 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 1.0 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.4 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.4 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 3.2 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 3.5 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.0 | 5.3 | GO:0042383 | sarcolemma(GO:0042383) |
0.0 | 0.3 | GO:0001739 | sex chromatin(GO:0001739) |
0.0 | 0.4 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.5 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.4 | GO:0097427 | microtubule bundle(GO:0097427) |
0.0 | 0.2 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.2 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.0 | 0.2 | GO:0000923 | equatorial microtubule organizing center(GO:0000923) |
0.0 | 0.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.1 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 0.2 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.8 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 1.9 | GO:0005796 | Golgi lumen(GO:0005796) |
0.0 | 1.2 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.0 | 7.4 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 1.0 | GO:0008305 | integrin complex(GO:0008305) |
0.0 | 0.0 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.0 | 2.2 | GO:0005643 | nuclear pore(GO:0005643) |
0.0 | 0.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 1.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
0.0 | 0.6 | GO:0030057 | desmosome(GO:0030057) |
0.0 | 1.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.2 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.9 | GO:0034704 | calcium channel complex(GO:0034704) |
0.0 | 0.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.0 | 0.5 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.0 | 0.5 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.6 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.5 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 1.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.4 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.0 | 0.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.0 | 0.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.1 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
0.0 | 0.2 | GO:0042555 | MCM complex(GO:0042555) |
0.0 | 0.2 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 0.1 | GO:0061617 | MICOS complex(GO:0061617) |
0.0 | 1.2 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 1.1 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.0 | 0.5 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 2.4 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.0 | 0.2 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.0 | 2.1 | GO:0032993 | protein-DNA complex(GO:0032993) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.0 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.9 | 2.7 | GO:0086057 | voltage-gated calcium channel activity involved in bundle of His cell action potential(GO:0086057) |
0.5 | 2.0 | GO:0032184 | SUMO polymer binding(GO:0032184) |
0.5 | 2.0 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.5 | 2.7 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.4 | 1.2 | GO:0098640 | integrin binding involved in cell-matrix adhesion(GO:0098640) |
0.4 | 2.3 | GO:0043183 | vascular endothelial growth factor receptor 1 binding(GO:0043183) |
0.4 | 3.3 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.3 | 1.0 | GO:0046970 | NAD-dependent histone deacetylase activity (H4-K16 specific)(GO:0046970) |
0.3 | 3.0 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.3 | 2.5 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.3 | 1.2 | GO:0004040 | amidase activity(GO:0004040) |
0.3 | 4.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.3 | 1.3 | GO:0032038 | myosin II heavy chain binding(GO:0032038) |
0.3 | 1.3 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.2 | 1.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.2 | 6.1 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
0.2 | 1.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 2.2 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.2 | 1.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.2 | 0.7 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.2 | 2.4 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.2 | 1.1 | GO:0010736 | serum response element binding(GO:0010736) |
0.2 | 2.3 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
0.2 | 0.6 | GO:0008160 | protein tyrosine phosphatase activator activity(GO:0008160) |
0.2 | 1.2 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.2 | 1.4 | GO:0035662 | Toll-like receptor 4 binding(GO:0035662) |
0.2 | 0.6 | GO:0070984 | SET domain binding(GO:0070984) |
0.2 | 0.7 | GO:0034602 | oxoglutarate dehydrogenase (NAD+) activity(GO:0034602) |
0.2 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.2 | 6.1 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.2 | 0.8 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.2 | 1.5 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.2 | 1.1 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.2 | 0.5 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.1 | 0.6 | GO:0005199 | structural constituent of cell wall(GO:0005199) |
0.1 | 0.4 | GO:0008841 | tetrahydrofolylpolyglutamate synthase activity(GO:0004326) dihydrofolate synthase activity(GO:0008841) |
0.1 | 2.3 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 2.9 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.6 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 3.6 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 2.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.1 | 1.0 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.1 | 0.9 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.9 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 0.3 | GO:0035034 | histone acetyltransferase regulator activity(GO:0035034) |
0.1 | 0.4 | GO:0072590 | N-acetyl-L-aspartate-L-glutamate ligase activity(GO:0072590) |
0.1 | 0.8 | GO:0070139 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.1 | 0.8 | GO:0019158 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
0.1 | 0.5 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 2.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
0.1 | 3.6 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.1 | 5.6 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 1.8 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.1 | 0.8 | GO:0050544 | icosatetraenoic acid binding(GO:0050543) arachidonic acid binding(GO:0050544) DBD domain binding(GO:0050692) |
0.1 | 0.3 | GO:0004608 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.1 | 2.1 | GO:0022848 | acetylcholine-gated cation channel activity(GO:0022848) |
0.1 | 0.7 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
0.1 | 6.6 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 1.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.5 | GO:0004471 | malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) malate dehydrogenase (decarboxylating) (NADP+) activity(GO:0004473) |
0.1 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.1 | 0.2 | GO:0051500 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.1 | 2.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.3 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
0.1 | 0.5 | GO:0031962 | mineralocorticoid receptor binding(GO:0031962) |
0.1 | 0.8 | GO:0070735 | protein-glycine ligase activity(GO:0070735) |
0.1 | 1.1 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.1 | 0.9 | GO:0048273 | mitogen-activated protein kinase p38 binding(GO:0048273) |
0.1 | 0.5 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.1 | 1.2 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.2 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.1 | 0.4 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.8 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.5 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.1 | 0.7 | GO:0031432 | titin binding(GO:0031432) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 1.3 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.1 | 0.2 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.1 | 0.3 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
0.1 | 0.7 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
0.1 | 1.0 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.1 | 0.8 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 0.2 | GO:0005026 | transforming growth factor beta receptor activity, type II(GO:0005026) |
0.1 | 11.5 | GO:0044325 | ion channel binding(GO:0044325) |
0.1 | 6.9 | GO:0032947 | protein complex scaffold(GO:0032947) |
0.0 | 0.3 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.0 | 0.3 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.0 | 0.8 | GO:0005049 | nuclear export signal receptor activity(GO:0005049) |
0.0 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.0 | 0.1 | GO:0050254 | rhodopsin kinase activity(GO:0050254) |
0.0 | 1.6 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0031626 | beta-endorphin binding(GO:0031626) |
0.0 | 0.3 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
0.0 | 0.2 | GO:0004667 | prostaglandin-D synthase activity(GO:0004667) |
0.0 | 0.2 | GO:0031728 | CCR3 chemokine receptor binding(GO:0031728) |
0.0 | 0.2 | GO:0004965 | G-protein coupled GABA receptor activity(GO:0004965) |
0.0 | 0.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.0 | 0.2 | GO:0032564 | adenyl deoxyribonucleotide binding(GO:0032558) dATP binding(GO:0032564) |
0.0 | 0.1 | GO:0047661 | racemase and epimerase activity, acting on amino acids and derivatives(GO:0016855) racemase activity, acting on amino acids and derivatives(GO:0036361) amino-acid racemase activity(GO:0047661) |
0.0 | 0.4 | GO:0031013 | troponin I binding(GO:0031013) |
0.0 | 1.9 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.0 | 0.2 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.0 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.0 | 0.4 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.7 | GO:0039706 | co-receptor binding(GO:0039706) |
0.0 | 0.9 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.8 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.0 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.3 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.0 | 0.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 1.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.0 | 0.4 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.5 | GO:0033558 | histone deacetylase activity(GO:0004407) protein deacetylase activity(GO:0033558) |
0.0 | 0.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.5 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) C-X-C chemokine binding(GO:0019958) |
0.0 | 0.3 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.0 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 3.0 | GO:0098531 | RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding(GO:0004879) transcription factor activity, direct ligand regulated sequence-specific DNA binding(GO:0098531) |
0.0 | 1.0 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.0 | 0.4 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.2 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.0 | 3.4 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.7 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.0 | 0.8 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.2 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.0 | 0.2 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.0 | 0.8 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 1.0 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.0 | 0.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.1 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.0 | 0.1 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.0 | 0.6 | GO:0016859 | cis-trans isomerase activity(GO:0016859) |
0.0 | 0.2 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
0.0 | 0.2 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.2 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.0 | 0.6 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.3 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.0 | 0.2 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.4 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) |
0.0 | 0.5 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 2.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.0 | 0.4 | GO:0003993 | acid phosphatase activity(GO:0003993) |
0.0 | 0.0 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.0 | 0.1 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.0 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.0 | 1.9 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.4 | GO:0017166 | vinculin binding(GO:0017166) |
0.0 | 0.5 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.0 | 0.4 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.2 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.9 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.0 | GO:0036033 | mediator complex binding(GO:0036033) |
0.0 | 0.6 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 0.3 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.4 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.2 | GO:0070035 | ATP-dependent DNA helicase activity(GO:0004003) ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
0.0 | 0.4 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.0 | 0.2 | GO:0003680 | AT DNA binding(GO:0003680) |
0.0 | 0.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.0 | 0.3 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.1 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
0.0 | 2.0 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 5.0 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 2.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.1 | 2.7 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 2.2 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.1 | 2.3 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 3.5 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 2.6 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.1 | 2.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 6.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.3 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.0 | 2.4 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 2.4 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.7 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 1.3 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.0 | 1.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.0 | 0.8 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.0 | 1.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 2.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 2.0 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 3.0 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 1.2 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.5 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 1.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 1.9 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.0 | 1.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.5 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.0 | 0.6 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.4 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.0 | 1.0 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.0 | 0.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 5.6 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.7 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.0 | 0.3 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 1.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 0.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 3.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 0.7 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 0.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 3.5 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 5.4 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 2.1 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 2.3 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.1 | 2.5 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 1.6 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.1 | 2.5 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.1 | 2.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 6.1 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.1 | 1.3 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.1 | 3.6 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 1.0 | REACTOME ENDOGENOUS STEROLS | Genes involved in Endogenous sterols |
0.0 | 1.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 1.9 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.0 | 0.8 | REACTOME ANDROGEN BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
0.0 | 2.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.0 | 1.8 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 2.3 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 2.9 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.0 | 2.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 1.7 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.0 | 1.0 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.0 | 1.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 0.9 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.5 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.0 | 3.5 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 1.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 1.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.4 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.0 | 0.8 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.0 | 0.6 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.3 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 1.3 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.0 | 0.7 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
0.0 | 0.7 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.0 | 1.1 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.0 | 1.7 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.7 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.0 | 0.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.0 | 0.7 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.0 | 1.4 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.0 | 1.0 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.9 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.3 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.2 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.0 | 0.6 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.0 | 1.4 | REACTOME L1CAM INTERACTIONS | Genes involved in L1CAM interactions |
0.0 | 0.3 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.0 | 0.3 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.2 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.0 | 0.4 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.0 | 0.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.6 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.5 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.0 | 1.0 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |